Medical Device Outsourcing Market: Trends, Growth Drivers, and Regional Outlook
The medical device outsourcing market has emerged as one of the most dynamic segments within the global healthcare industry, as manufacturers increasingly turn to external partners for design, development, manufacturing, and quality support. Medical device outsourcing refers to the practice of appointing outside partners to help design, develop, test, and manufacture devices instead of managing every function in-house. It typically includes contract design teams, engineering support, component and consumable manufacturing, assembly, packaging, and quality documentation. According to Fortune Business Insight, the global medical device outsourcing market size was valued at USD 154.54 billion in 2025 and is projected to grow from USD 164.08 billion in 2026 to USD 278.81 billion by 2034, exhibiting a CAGR of 6.9% during the forecast period.
Market Overview
The steady expansion of this market is being driven by a combination of cost pressures and strategic priorities within medical device companies. According to Fortune Business Insight, growth is attributed to a rising emphasis on reduced operational costs, sharper focus on core competencies, improved cash flow, and superior operational efficiency. Technological developments, combined with the globalization of the healthcare sector, are also expected to have a positive impact on market expansion. Notably, according to Fortune Business Insight, North America dominated the global medical device outsourcing market with a market share of 37.79% in 2025.
Key industry players such as Flex Ltd., Jabil Inc., TE Connectivity, Sanmina Corporation, and Integer Holdings Corporation continue to focus on developing innovative technologies to offer improved accuracy and efficiency to their clients.
Key Market Trends
One of the most notable trends shaping the industry is the rising preference among medical device manufacturers to outsource quality-related and compliance activities, including documentation support, process validation, and regulatory preparation. As compliance requirements grow stricter, maintaining large in-house quality teams becomes costly and time-consuming, prompting companies to rely on outsourcing partners that already possess the necessary infrastructure to handle these processes efficiently and reduce turnaround time.
Market Drivers, Restraints, and Opportunities
A major driver fueling this market is the ability of outsourcing partners to enable faster product launches with fewer in-house resources. Outsourcing companies are typically equipped with extensive infrastructure that reduces overall process time and minimizes bottlenecks through regulated processes, helping device companies meet short timelines and high expectations for safety and performance.
However, the market does face certain restraints. Loss of control over internal processes and dependency on third-party companies is projected to negatively affect growth, as device companies must rely on partner timelines, staffing, and quality culture. Concerns around protecting confidential designs and the difficulty of switching partners once tools, documents, and know-how sit outside the original equipment manufacturer (OEM) also pose challenges.
On the opportunity side, one-stop, design-to-manufacturing partnerships are gaining traction. Many device makers prefer fewer vendors and smoother handoffs between design and mass production, creating opportunities for outsourcing firms to offer end-to-end services under a single contract. Industry consolidation, with contract development and manufacturing organizations (CDMOs) acquiring design houses and specialty manufacturers, further supports this trend.
A key challenge remains managing quality consistency across multiple manufacturing sites and sub-suppliers, often located in different countries, which requires strong documentation, training, and frequent audits.
Market Segmentation
According to Fortune Business Insight, the market is segmented by outsourced service type, device class, device type, application, and end-user. The design and development services segment is anticipated to hold the largest market share, as this phase requires specialized skills and equipment that many device companies cannot maintain in-house. Meanwhile, the regulatory, quality & clinical support services segment is anticipated to rise at a CAGR of 7.9% during the forecast period.
By device class, the Class II segment dominated the market in 2025, given the stronger controls, testing, and documentation required for higher-risk devices. By device type, consumables led the market due to steady, repeat demand for items like tubing sets, catheters, and disposables. By application, the cardiovascular segment dominated in 2025, while the respiratory segment is expected to grow at a CAGR of 7.3%. By end-user, medical device companies held the highest share and are set to account for 77.4% of the market in 2026.
Regional Outlook
According to Fortune Business Insight, North America generated USD 58.45 billion in 2025 and remains the leading region, supported by product launches, cost optimization, and a stronger focus on core business functions. The U.S. market is estimated at USD 52.81 billion in 2026, accounting for approximately 32.2% of global revenue.
Europe is projected to reach USD 47.53 billion in 2026, driven by rising investment in product development and an expanding base of outsourcing service providers. Within Europe, Germany is projected to reach approximately USD 10.69 billion in 2026, while the U.K. is estimated at around USD 7.71 billion.
Asia Pacific is expected to attain USD 43.91 billion in 2026, supported by growing healthcare demand and favorable government initiatives. China is estimated at around USD 14.57 billion in 2026, while India is projected to reach approximately USD 9.74 billion.
Competitive Landscape
According to Fortune Business Insight, the market holds a semi-consolidated structure, with prominent players including Flex Ltd., Jabil Inc., TE Connectivity, Sanmina Corporation, and Integer Holdings Corporation, alongside notable companies such as Plexus Corp., Celestica HealthTech, West Pharmaceutical Services, Phillips-Medisize, and Nextern. These companies continue to prioritize collaborations and strategic acquisitions to strengthen their global presence.
Conclusion
With a projected CAGR of 6.9% through 2034, the medical device outsourcing market is set for sustained expansion, driven by cost efficiency, faster product launches, and growing demand for specialized regulatory and quality support. As consolidation continues and one-stop outsourcing models gain popularity, the industry is well-positioned for continued transformation over the coming decade.
What's Driving Japan's Market? Discover the Latest "Medical Device Outsourcing Market" Insights